BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 28460484)

  • 1. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
    Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
    Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12.
    Akcora BÖ; Storm G; Bansal R
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):804-818. PubMed ID: 29217140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells.
    Yu W; Li L; Zheng F; Yang W; Zhao S; Tian C; Yin W; Chen Y; Guo W; Zou L; Deng W
    Cell Physiol Biochem; 2017; 44(2):467-478. PubMed ID: 29141249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
    Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
    Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
    Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S
    Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICG-001 suppresses growth of gastric cancer cells and reduces chemoresistance of cancer stem cell-like population.
    Liu Y; Chen H; Zheng P; Zheng Y; Luo Q; Xie G; Ma Y; Shen L
    J Exp Clin Cancer Res; 2017 Sep; 36(1):125. PubMed ID: 28893318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL
    Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth.
    Arensman MD; Telesca D; Lay AR; Kershaw KM; Wu N; Donahue TR; Dawson DW
    Mol Cancer Ther; 2014 Oct; 13(10):2303-14. PubMed ID: 25082960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.
    Gang EJ; Hsieh YT; Pham J; Zhao Y; Nguyen C; Huantes S; Park E; Naing K; Klemm L; Swaminathan S; Conway EM; Pelus LM; Crispino J; Mullighan CG; McMillan M; Müschen M; Kahn M; Kim YM
    Oncogene; 2014 Apr; 33(17):2169-78. PubMed ID: 23728349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt/β-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours.
    Wend P; Fang L; Zhu Q; Schipper JH; Loddenkemper C; Kosel F; Brinkmann V; Eckert K; Hindersin S; Holland JD; Lehr S; Kahn M; Ziebold U; Birchmeier W
    EMBO J; 2013 Jul; 32(14):1977-89. PubMed ID: 23736260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrandrine inhibits glioma stem-like cells by repressing β-catenin expression.
    Zhang Y; Wen YL; Ma JW; Ye JC; Wang X; Huang JX; Meng CY; Xu XZ; Wang SX; Zhong XY
    Int J Oncol; 2017 Jan; 50(1):101-110. PubMed ID: 27909720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists.
    Zhao Y; Wu K; Wu Y; Melendez E; Smbatyan G; Massiello D; Kahn M
    Curr Mol Pharmacol; 2018; 11(2):113-121. PubMed ID: 28933312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia.
    Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C
    J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of β-catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair.
    Moheimani F; Roth HM; Cross J; Reid AT; Shaheen F; Warner SM; Hirota JA; Kicic A; Hallstrand TS; Kahn M; Stick SM; Hansbro PM; Hackett TL; Knight DA
    Int J Biochem Cell Biol; 2015 Nov; 68():59-69. PubMed ID: 26315281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of inhibition of CBP-coactivated β-catenin-mediated Wnt signalling in uremic rats with vascular calcifications.
    Gravesen E; Nordholm A; Mace M; Morevati M; Høgdall E; Nielsen C; Kjær A; Olgaard K; Lewin E
    PLoS One; 2018; 13(8):e0201936. PubMed ID: 30075015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt/β-catenin signaling and induction of apoptosis.
    Jiang Y; Sheng H; Meng L; Yue H; Li B; Zhang A; Dong Y; Liu Y
    World J Surg Oncol; 2017 Jan; 15(1):9. PubMed ID: 28061901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin signaling inhibitor ICG-001 enhances pigmentation of cultured melanoma cells.
    Kim KI; Jeong DS; Jung EC; Lee JH; Kim CD; Yoon TJ
    J Dermatol Sci; 2016 Nov; 84(2):160-168. PubMed ID: 27567978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells.
    Wiese M; Hamdan FH; Kubiak K; Diederichs C; Gielen GH; Nussbaumer G; Carcaboso AM; Hulleman E; Johnsen SA; Kramm CM
    Cell Death Dis; 2020 Aug; 11(8):673. PubMed ID: 32826850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.